CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Net Sales		$ 19,381	$ 18,109	$ 60,672	$ 57,172
Cost of Products Sold		10,326	8,922	31,355	27,317
Selling, General and Administrative Expense		5,031	5,402	15,102	15,409
Operating Income		4,024	3,785	14,215	14,446
Interest Expense		(109)	(106)	(324)	(385)
Interest Income		9	11	30	30
Other Non-operating Income/(Loss), Net		147	187	424	(40)
Earnings/(Loss) from Continuing Operations Before Income Taxes		4,071	3,877	14,345	14,051
Income Taxes on Continuing Operations		704	628	2,610	2,607
Net Earnings		3,367	3,249	11,735	11,444
Net Income (Loss) Attributable to Noncontrolling Interest		12	(20)	45	44
Net Income (Loss) Attributable to Parent		$ 3,355	$ 3,269	$ 11,690	$ 11,400
Basic Net Earnings Per Common Share
Basic Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.37	$ 1.30	$ 4.76	$ 4.53
Diluted Net Earnings Per Common Share
Diluted Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.33	$ 1.26	$ 4.59	$ 4.37
Diluted Weighted Average Common Shares Outstanding		2,530.2	2,590.3	2,544.4	2,610.4

[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.